ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
알레르기 치료 시장 규모는 2025년 309억 1,000만 달러에서 2026-2034년에 CAGR 6.33%로 성장하며, 2034년에는 537억 달러에 달할 것으로 예측되고 있습니다.
알레르기 치료 시장은 알레르기 질환 증가 추세와 치료 옵션에 대한 인식이 높아짐에 따라 견고한 성장세를 보이고 있습니다. 알레르기는 호흡기 질환, 피부 반응 또는 위장 장애로 나타날 수 있으며, 전 세계 인구의 상당수에게 영향을 미치고 있습니다. 개인이 알레르기가 삶의 질에 미치는 영향에 대한 인식이 높아짐에 따라 효과적인 치료 솔루션에 대한 수요가 증가하고 있습니다. 이 시장에는 항히스타민제, 코르티코스테로이드, 면역요법, 생물제제 등 증상 완화와 환자의 건강 상태를 개선하기 위한 다양한 치료법이 포함되어 있습니다.
또한 알레르기 치료 기술의 발전은 시장내 혁신을 촉진하고 있습니다. 설하 면역요법 및 모노클로널 항체 개발은 알레르기 관리 방법에 혁명을 가져왔으며, 환자들에게 보다 편리하고 효과적인 치료 옵션을 제공합니다. 이러한 치료법은 알레르기의 근본 원인을 해결할 뿐만 아니라 장기적인 완화를 가져오고 지속적인 약물 복용의 필요성을 줄여줍니다. 새로운 치료법 및 투여 방법에 대한 연구가 계속되는 가운데, 알레르기 치료 시장은 환자들의 치료 결과 개선과 삶의 질 향상에 대한 가능성에 힘입어 더욱 확대될 것으로 예측됩니다.
또한 예방의료와 환자 교육에 대한 중요성이 높아지고 있는 것도 알레르기 치료의 전망을 형성하고 있습니다. 의료 서비스 프로바이더들은 알레르겐 회피 및 관리 전략에 대해 환자를 교육하는 것이 중요하다는 것을 점점 더 많이 인식하고 있습니다. 이러한 적극적인 접근 방식은 개인이 자신의 알레르기를 관리할 수 있는 권한을 부여할 뿐만 아니라 환자와 의료 서비스 프로바이더 간의 협력 관계를 형성합니다. 알레르기 치료 시장이 계속 진화하는 가운데, 혁신적인 치료법, 환자 중심의 치료, 예방에 대한 집중의 조합은 미래 성장을 가속하는 데 중요한 역할을 할 것입니다.
목차
제1장 서론
제2장 개요
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 알레르기 치료 시장 : 치료 유형별
제5장 세계의 알레르기 치료 시장 : 알레르기유형별
제6장 세계의 알레르기 치료 시장 : 유통 채널별
제7장 세계의 알레르기 치료 시장 : 최종사용자별
제8장 세계의 알레르기 치료 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
KSA
영문 목차
영문목차
The Allergy Treatment Market size is expected to reach USD 53.70 Billion in 2034 from USD 30.91 Billion (2025) growing at a CAGR of 6.33% during 2026-2034.
The allergy treatment market is experiencing robust growth, driven by the increasing prevalence of allergic conditions and the rising awareness of available treatment options. Allergies, which can manifest as respiratory issues, skin reactions, or gastrointestinal disturbances, affect a significant portion of the global population. As individuals become more aware of the impact of allergies on their quality of life, the demand for effective treatment solutions is on the rise. This market encompasses a wide range of therapies, including antihistamines, corticosteroids, immunotherapy, and biologics, all aimed at alleviating symptoms and improving patient well-being.
Moreover, advancements in allergy treatment technologies are propelling innovation within the market. The development of sublingual immunotherapy and monoclonal antibodies has revolutionized the way allergies are managed, offering patients more convenient and effective options. These therapies not only target the underlying causes of allergies but also provide long-term relief, reducing the need for continuous medication. As research continues to explore new treatment modalities and delivery methods, the allergy treatment market is likely to expand further, driven by the promise of improved patient outcomes and enhanced quality of life.
Additionally, the growing emphasis on preventive care and patient education is shaping the allergy treatment landscape. Healthcare providers are increasingly recognizing the importance of educating patients about allergen avoidance and management strategies. This proactive approach not only empowers individuals to take control of their allergies but also fosters a collaborative relationship between patients and healthcare providers. As the allergy treatment market continues to evolve, the combination of innovative therapies, patient-centered care, and a focus on prevention will play a crucial role in driving its future growth.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Treatment Type
Antihistamines
Corticosteroids
Decongestants
Immunotherapy
Others
By Allergy Type
Food Allergy
Skin Allergy
Dust Allergy
Pet Allergy
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By End-User
Hospitals
Clinics
Homecare
Others
COMPANIES PROFILED
Sanofi, GlaxoSmithKline plc, Johnson Johnson Services Inc, Merck Co Inc, Pfizer Inc, AstraZeneca, Novartis AG, Bayer AG, F HoffmannLa Roche Ltd, AbbVie Inc, Amgen Inc, Teva Pharmaceutical Industries Ltd, Mylan NV, ALKAbell AS, Stallergenes Greer
We can customise the report as per your requriements
TABLE OF CONTENTS
Chapter 1. PREFACE
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1 Information Analysis
1.3.2 Market Formulation & Data Visualization
1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
3.4.1 Standards & Compliance
3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
3.5.1 Market Drivers
3.5.2 Market Restraints
3.5.3 Market Opportunities
3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis
Chapter 4. GLOBAL ALLERGY TREATMENT MARKET: BY TREATMENT TYPE 2022-2034 (USD MN)
4.1. Market Analysis, Insights and Forecast Treatment Type
4.2. Antihistamines Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Corticosteroids Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Decongestants Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Immunotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL ALLERGY TREATMENT MARKET: BY ALLERGY TYPE 2022-2034 (USD MN)
5.1. Market Analysis, Insights and Forecast Allergy Type
5.2. Food Allergy Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Skin Allergy Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Dust Allergy Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Pet Allergy Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL ALLERGY TREATMENT MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)
6.1. Market Analysis, Insights and Forecast Distribution Channel
6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL ALLERGY TREATMENT MARKET: BY END-USER 2022-2034 (USD MN)
7.1. Market Analysis, Insights and Forecast End-user
7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL ALLERGY TREATMENT MARKET: BY REGION 2022-2034(USD MN)
8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.2.1 By Treatment Type
8.2.2 By Allergy Type
8.2.3 By Distribution Channel
8.2.4 By End-user
8.2.5 United States
8.2.6 Canada
8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.3.1 By Treatment Type
8.3.2 By Allergy Type
8.3.3 By Distribution Channel
8.3.4 By End-user
8.3.5 United Kingdom
8.3.6 France
8.3.7 Germany
8.3.8 Italy
8.3.9 Russia
8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.4.1 By Treatment Type
8.4.2 By Allergy Type
8.4.3 By Distribution Channel
8.4.4 By End-user
8.4.5 India
8.4.6 Japan
8.4.7 South Korea
8.4.8 Australia
8.4.9 South East Asia
8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.5.1 By Treatment Type
8.5.2 By Allergy Type
8.5.3 By Distribution Channel
8.5.4 By End-user
8.5.5 Brazil
8.5.6 Argentina
8.5.7 Peru
8.5.8 Chile
8.5.9 South East Asia
8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.6.1 By Treatment Type
8.6.2 By Allergy Type
8.6.3 By Distribution Channel
8.6.4 By End-user
8.6.5 Saudi Arabia
8.6.6 UAE
8.6.7 Israel
8.6.8 South Africa
8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL ALLERGY TREATMENT INDUSTRY
